Screening for
Animals
Antibiotics, Antineoplastic
/ administration & dosage
Cancer Survivors
Cardiotoxicity
/ diagnosis
Disease Models, Animal
Doxorubicin
/ administration & dosage
Echocardiography
Heart Ventricles
/ diagnostic imaging
Humans
Injections, Intravenous
Longitudinal Studies
Male
Myocardial Contraction
/ drug effects
Myocytes, Cardiac
/ drug effects
Neoplasms
/ drug therapy
Rats
Rats, Wistar
Stroke Volume
/ drug effects
Ventricular Function, Left
/ drug effects
Anthracyclines
cardiotoxicity
heart failure
myofilament
regional speckle tracking echocardiography
Journal
Theranostics
ISSN: 1838-7640
Titre abrégé: Theranostics
Pays: Australia
ID NLM: 101552395
Informations de publication
Date de publication:
2020
2020
Historique:
received:
24
04
2020
accepted:
18
06
2020
entrez:
30
7
2020
pubmed:
30
7
2020
medline:
6
5
2021
Statut:
epublish
Résumé
Anthracyclines are key chemotherapeutic agents used in various adult and pediatric cancers, however, their clinical use is limited due to possible congestive heart failure (HF) caused by acute and irreversible cardiotoxicity. Currently, there is no method to predict the future development of the HF in these patients. In order to identify early biomarkers to predict anthracycline cardiotoxicity in long-term survivors of childhood cancer, this longitudinal study aimed to analyze early and late
Identifiants
pubmed: 32724462
doi: 10.7150/thno.47407
pii: thnov10p8130
pmc: PMC7381739
doi:
Substances chimiques
Antibiotics, Antineoplastic
0
Doxorubicin
80168379AG
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
8130-8142Informations de copyright
© The author(s).
Déclaration de conflit d'intérêts
Competing Interests: The authors have declared that no competing interest exists.
Références
J Clin Ultrasound. 2017 May;45(4):222-230
pubmed: 27910996
J Am Soc Echocardiogr. 2019 Mar;32(3):412-422
pubmed: 30679141
Support Care Cancer. 2016 Jul;24(7):3139-45
pubmed: 26923461
Eur Heart J Cardiovasc Imaging. 2013 Feb;14(2):175-82
pubmed: 22802431
Theranostics. 2016 Jun 06;6(9):1277-92
pubmed: 27375779
Lancet Oncol. 2015 Mar;16(3):e123-36
pubmed: 25752563
Echocardiography. 2018 Feb;35(2):234-240
pubmed: 29106752
J Am Coll Cardiol. 2010 Sep 7;56(11):867-74
pubmed: 20688032
Biomed Res Int. 2016;2016:9363951
pubmed: 26942202
Circulation. 2015 Jun 2;131(22):1981-8
pubmed: 25948538
Proc Natl Acad Sci U S A. 2014 Feb 4;111(5):2011-6
pubmed: 24449919
Int J Cardiovasc Imaging. 2018 Sep;34(9):1373-1381
pubmed: 29611048
Echocardiography. 2011 Aug;28(7):738-45
pubmed: 21615484
Lancet Oncol. 2017 Aug;18(8):e445-e456
pubmed: 28759384
Br J Clin Pharmacol. 2016 Sep;82(3):683-95
pubmed: 27197003
J Am Coll Cardiol. 2014 Sep 2;64(9):938-45
pubmed: 25169180
Am J Physiol Heart Circ Physiol. 2019 Feb 1;316(2):H360-H370
pubmed: 30499711
J Am Soc Echocardiogr. 2007 Dec;20(12):1351-8
pubmed: 17604960
J Clin Oncol. 2008 Mar 10;26(8):1201-3
pubmed: 18227525
Heart. 2010 Jul;96(14):1137-41
pubmed: 20511624
Nat Med. 2012 Nov;18(11):1639-42
pubmed: 23104132
J Cardiovasc Echogr. 2013 Jan-Mar;23(1):33-38
pubmed: 28465881
Theranostics. 2019 Jan 24;9(3):747-760
pubmed: 30809306
Prog Cardiovasc Dis. 2014 Jul-Aug;57(1):111-24
pubmed: 25081406
Cardiovasc Res. 2019 Apr 15;115(5):922-934
pubmed: 30768157
J Pharmacol Exp Ther. 2011 Dec;339(3):807-14
pubmed: 21934029
Front Physiol. 2013 Nov 20;4:336
pubmed: 24312057
Am J Physiol Heart Circ Physiol. 2010 Sep;299(3):H723-30
pubmed: 20562337
J Cardiovasc Magn Reson. 2010 May 24;12:31
pubmed: 20497525
Antioxid Redox Signal. 2013 Mar 20;18(9):1009-20
pubmed: 22978600
Eur J Heart Fail. 2011 Jan;13(1):1-10
pubmed: 21169385
Eur J Echocardiogr. 2006 Mar;7(2):79-108
pubmed: 16458610
JACC Cardiovasc Imaging. 2008 May;1(3):366-76
pubmed: 19356451
J Biol Chem. 2011 Mar 25;286(12):9921-7
pubmed: 21257753
J Am Coll Cardiol. 2017 Nov 14;70(20):2536-2551
pubmed: 29145954
FASEB J. 2005 Jan;19(1):88-90
pubmed: 15498894
Circ Heart Fail. 2015 Jan;8(1):98-108
pubmed: 25420486
Eur J Heart Fail. 2014 Mar;16(3):300-8
pubmed: 24464946
BMC Cancer. 2018 Oct 25;18(1):1037
pubmed: 30359235
N Engl J Med. 1998 Sep 24;339(13):900-5
pubmed: 9744975
Heart. 2018 Jun;104(12):971-977
pubmed: 29217634
J Am Soc Echocardiogr. 2014 Sep;27(9):911-39
pubmed: 25172399
Theranostics. 2019 Aug 14;9(21):6080-6098
pubmed: 31534538
Am J Cardiol. 2011 Feb 1;107(3):472-7
pubmed: 21257017
Int J Cardiol. 2018 May 1;258:207-216
pubmed: 29544934
Pediatr Cardiol. 2015 Dec;36(8):1610-6
pubmed: 26049414
J Cancer Surviv. 2012 Mar;6(1):95-101
pubmed: 21630046
JAMA. 1991 Sep 25;266(12):1672-7
pubmed: 1886191
Mol Cell Proteomics. 2006 Feb;5(2):215-25
pubmed: 16223748
Theranostics. 2018 May 9;8(12):3176-3188
pubmed: 29930721
Pediatrics. 2012 Dec;130(6):1003-11
pubmed: 23166343
N Engl J Med. 1991 Mar 21;324(12):808-15
pubmed: 1997853
J Am Soc Echocardiogr. 2012 Jul;25(7):733-40
pubmed: 22578518
J Cardiovasc Pharmacol. 2007 Dec;50(6):647-53
pubmed: 18091581
Cardiovasc Res. 2006 Feb 1;69(2):370-80
pubmed: 16380103
Front Pharmacol. 2015 Aug 10;6:166
pubmed: 26321952